Home › Investors bet Sun Pharma can restore...
 

Keywords :   


Investors bet Sun Pharma can restore...

2014-04-13 10:09:37| Chemicals - Topix.net

On the surface, Sun Pharma's $3.2-billion purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal.

Tags: sun bet investors restore

Category:Chemicals

Latest from this category

All news
05.11BASF Opens New Production Line in Heerenveen, the Netherlands
05.11Registration Now Open for RadTech 2025
05.11Teknos Poland Honored by Farby i Lakiery
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11U.S. Green Building Council Announces 2024 Leadership Award Recipients
04.11ASTM International Publishes New Standards for FT4 Powder Rheometer Procedures
Chemicals »
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »